Todd S. Young's Net Worth
$3.32 Million
Who is Todd S. Young?
Todd S. Young has an estimated net worth of $3.32 Million. This is based on reported shares across multiple companies, which include Elanco Animal Health Inc, and ACADIA PHARMACEUTICALS INC.
SEC CIK
Todd S. Young's CIK is 0001682584
Past Insider Trading and Trends
2018 was Todd S. Young's most active year for acquiring shares with 4 total transactions. Todd S. Young's most active month to acquire stocks was the month of February. 2023 was Todd S. Young's most active year for disposing of shares, totalling 5 transactions. Todd S. Young's most active month to dispose stocks was the month of February. 2019 saw Todd S. Young paying a total of $265,700.00 for 19,900 shares, this is the most they've acquired in one year. In 2022 Todd S. Young cashed out on 28,439 shares for a total of $756,384.04, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Elanco Animal Health Inc (ELAN) Snapshot price: $15.09
SEE REMARKS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.20% | 29.9K |
$16.03 | -$224,420.00 | 256.49K |
Mar 1 - Mar 5
| |||
Form 4
| +23.15% | 20.36K |
$16.46 | -$264,742.64 | 108.27K |
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
| 206.23K |
Mar 14 - Mar 15
| |||
Form 4
| +22.30% | 37.61K |
$11.01 | -$319,829.49 | 206.23K |
Mar 2
| |||
Form 4
| +17.29% | 50.26K |
$11.14 | -$87,278.00 | 341.03K |
Mar 1 - Mar 2
| |||
Form 4
| +31.24% | 1.56K |
—
|
—
| 6.56K |
Feb 1
| |||
Form 4
| +15.17% | 15.8K |
$28.96 | -$170,353.18 | 119.95K |
Mar 1 - Mar 2
| |||
Form 4
| +45.66% | 32.65K |
$25.98 | -$586,030.86 | 104.15K |
Feb 22
| |||
Form 4
| +22.22% | 13K |
$32.81 | -$87,655.67 | 71.5K |
Mar 1 - Mar 2
| |||
Form 4
| +45.42% | 18.27K |
$30.58 | -$236,138.76 | 58.5K |
Feb 22
| |||
Form 4
| -3.09% | -1.28K |
$29.20 | -$37,492.80 | 40.23K |
Dec 3
| |||
Form 4
|
∞
| 7K |
$23.90 | $167,400.00 | 7K |
Aug 3
| |||
Form 4
| +50.41% | 13.91K |
$27.40 | -$25,372.40 | 41.51K |
Mar 1 - Mar 2
| |||
Form 4
| -4.45% | -1.28K |
$27.30 | -$35,053.20 | 27.6K |
Dec 3
| |||
Form 4
| +52.96% | 10K |
$26.57 | $265,700.00 | 28.88K |
Sep 4
| |||
Form 4
| +110.21% | 9.9K |
—
|
—
| 18.88K |
Mar 1
| |||
Form 4
|
∞
| 8.98K |
—
|
—
| 8.98K |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
EVP AND CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||